Orezone to Announce Third Quarter 2022 Financial Results and Host a Webcast and Conference Call on November 14, 2022
VANCOUVER, British Columbia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) ("Orezone") will report its 2022 third quarter financial results on Monday, November 14, 2022. Orezone will host a webcast and conference call on the same day to discuss the results and provide an operational and exploration update.
Conference Call Toll-free in U.S. and Canada: 1-866-652-5200 International callers: +412-317-6060
About Orezone Gold Corporation
Orezone is Canadian mining company operating the open pit Bomboré Gold Mine in Burkina Faso. The Bomboré Gold Mine construction was recently completed under budget, poured first gold in September and is expected to achieve commercial production in Q4-2022.
For further information, please contact:
Patrick Downey President and Chief Executive Officer
AudioCodes , a leading vendor of advanced communications software, products and productivity solutions for the digital workplace, today announced that it will release financial results for its Second quarter 2024 on Tuesday, July 30, 2024, before the...
Avicenna.AI, a leading medical imaging AI company, has received Medical Device Regulation (MDR) certificate for five of its algorithms from certification body BSI Medical Devices. This development means the company's product portfolio is fully...
M-Files, the leader in knowledge work automation, today announced that the company has been honored as the Gold Winner in the Information Technology Disruptors category of the 4th Annual 2024 Globee® Awards for Disruptors.
The Globee Awards for...
Ryan, a leading global tax services and software provider, is pleased to announce the Firm has been named one of the Top Workplaces in Arizona for 2024. This marks the 11th year Ryan has been named to the prestigious list by Top Workplaces.
"At...
Appgate, the secure access company, today announced the successful completion of its recapitalization process and transition to a private company. Post emergence, the company has significantly strengthened its financial position with no issued...
Insmed Incorporated , a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that additional positive results from the ASPEN...
